Sweeping US Health Policy Changes Unfold: HHS Directives, ACA Overhaul Proposed, Congress Acts on Funding

WASHINGTON D.C. – Monday, March 10, 2025, marked a significant day for U.S. health policy, witnessing a series of major developments from the executive branch and Congress impacting everything from vaccine data integrity and federal health agency staffing to healthcare affordability under the Affordable Care Act and the future of telehealth.

HHS Initiatives and Workforce Changes

At the Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy Jr., key directives were issued. Among the most prominent was a mandate directing the Centers for Disease Control and Prevention (CDC) to undertake a comprehensive reinvestigation of existing vaccine data. This move signals a heightened scrutiny of vaccine efficacy and safety information under the current administration.

In tandem with this, the CDC itself announced the development and planned implementation of a new tool designed to proactively identify and address conflicts of interest among researchers and staff. This initiative appears aimed at bolstering public trust and ensuring the integrity of the agency’s scientific findings.

Simultaneously, HHS unveiled a substantial voluntary separation incentive payment program as part of President Donald Trump’s broader government cost-cutting efforts. The program offers a payment of up to $25,000 to most of the department’s approximately 80,000 federal employees, including staff at critical agencies such as the CDC, the Food and Drug Administration (FDA), and the National Institutes of Health (NIH). Employees considering the offer have a tight deadline, with responses required by March 14, 2025.

Adding another layer to the health policy landscape, some Republican lawmakers introduced proposed legislation this week specifically aiming to ban the use of mRNA vaccines. The introduction of this bill reflects ongoing political debates surrounding vaccine technologies and mandates.

Proposed Overhaul of the Affordable Care Act

More stories

Black Physicians Raise Alarm Over Policy Shifts Impacting Public Health, Healthcare Equity

February 4, 2025

Federal Cuts Gut US Public Health Capacity Amid Rising Disease Threats, AP Reports

May 31, 2025

Federal Health Policy Navigates Funding Cliffs, Program Reforms, and Executive Directives

February 20, 2025

Trump Administration Cancels Key mRNA Vaccine Contract, Sparking Biosecurity Warnings

June 6, 2025

A major policy proposal emerged from the Trump administration on March 10, 2025, concerning the Affordable Care Act (ACA). The administration issued a proposed rule that, if implemented, would fundamentally alter key aspects of health insurance enrollment and coverage under the act.

The proposed changes include significantly shortening the annual open enrollment period, mandating that it end on December 15. It also seeks to eliminate the current provision allowing monthly enrollment for individuals whose income is below 150 percent of the federal poverty level (FPL). Furthermore, the rule proposes reducing subsidies for individuals who do not promptly verify their income, potentially making coverage less affordable for many.

Perhaps the most contentious elements of the proposed rule involve eligibility and covered services. The rule explicitly aims to exclude Deferred Action for Childhood Arrivals (DACA) recipients from obtaining coverage through the ACA marketplaces. Additionally, it seeks to remove gender-affirming care as a mandated essential health benefit that plans must cover, a change that would have significant implications for transgender individuals seeking healthcare.

Congressional Action on Funding and Healthcare Access

Amidst these executive actions, the U.S. House of Representatives took legislative steps to address pressing healthcare funding issues. The House passed a stopgap funding measure intended to avert immediate disruptions to various health programs.

The measure includes several critical provisions: it extends current Medicare telehealth flexibilities, a key concern given the potential expiration of these provisions on March 31, 2025; it delays planned cuts to disproportionate share hospitals (DSH), which provide care to a high percentage of low-income patients; and it provides a six-month funding extension for certain other health programs. Notably absent from the stopgap measure, however, was any provision for a Medicare physician pay increase, a priority for many healthcare providers.

The passage of this bill comes as discussions continue regarding the future of the pandemic-era Medicare telehealth flexibilities, highlighting ongoing uncertainty about patients’ ability to access remote care services beyond the end of the month.

Other Public Health Concerns Highlighted

The news cycle on March 10, 2025, also touched upon other significant public health challenges. Updates were reported on the ongoing measles outbreak, underscoring persistent concerns about vaccine-preventable diseases. Disparities in rural healthcare access remained a focus, attributed largely to persistent doctor shortages and limited access to reliable telehealth infrastructure in underserved areas.

Separately, scrutiny continued regarding the FDA’s process for evaluating chemicals present in the food supply, a long-standing area of public health concern. Adding to the day’s health policy alerts, the Centers for Medicare & Medicaid Services (CMS) issued guidance alerting hospitals to potential upcoming restrictions related to gender-affirming care specifically for minors, signaling potential policy shifts at the state or federal level affecting pediatric care.

Taken together, the events of March 10, 2025, illustrate a dynamic and rapidly shifting landscape in U.S. health policy, driven by new administration priorities, legislative maneuvering, and ongoing public health challenges.